Table 7.
The correlation between TNFAIP2 rs8126 polymorphism and gastric cancer (GC) prognosis in the subgroup analysis.
| Parameters | Genotype | GC | Death | Median survival time (mean) | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|---|---|---|---|
| P-value | HR (95% CI) | P-value* | HR (95% CI) | |||||
| rs8126 | n = 287 | n = 120 | ||||||
| Gender | ||||||||
| Male | TT | 103 | 44 | 56.3b | ||||
| TC | 79 | 32 | 79.0a | 0.843 | 0.955 (0.606–1.506) | 0.488 | 1.177 (0.743–1.864) | |
| CC | 29 | 13 | 68.0a | 0.961 | 1.016 (0.547–1.886) | 0.795 | 1.087 (0.579–2.039) | |
| CC + TC vs. TT | 0.892 | 0.972 (0.641–1.472) | 0.499 | 1.156 (0.760–1.758) | ||||
| CC vs. TC + TT | 0.912 | 1.034 (0.574–1.862) | 0.948 | 1.020 (0.562–1.850) | ||||
| Female | TT | 34 | 14 | 50.4b | ||||
| TC | 30 | 12 | 51.8b | 0.943 | 1.029 (0.476–2.225) | 0.762 | 1.132 (0.506–2.532) | |
| CC | 12 | 5 | 54.3b | 0.700 | 1.223 (0.439–3.405) | 0.081 | 2.729 (0.883–8.431) | |
| CC + TC vs. TT | 0.846 | 1.073 (0.529–2.177) | 0.522 | 1.275 (0.606–2.679) | ||||
| CC vs. TC + TT | 0.719 | 1.192 (0.457–3.112) | 0.278 | 1.733 (0.641–4.681) | ||||
| Age (years) | n = 287 | n = 120 | ||||||
| ≥60 | TT | 65 | 29 | 58.0a | ||||
| TC | 51 | 23 | 57.0a | 0.925 | 1.027 (0.593–1.776) | 0.506 | 1.210 (0.690–2.124) | |
| CC | 20 | 7 | 58.9b | 0.400 | 0.701 (0.307–1.603) | 0.570 | 0.783 (0.336–1.823) | |
| CC + TC vs. TT | 0.765 | 0.925 (0.555–1.543) | 0.788 | 1.074 (0.638–1.809) | ||||
| CC vs. TC + TT | 0.371 | 0.697 (0.317–1.536) | 0.446 | 0.732 (0.329–1.632) | ||||
| <60 | TT | 72 | 29 | 53.8b | ||||
| TC | 58 | 21 | 79.0a | 0.673 | 0.886 (0.505–1.554) | 0.968 | 1.012 (0.570–1.797) | |
| CC | 21 | 11 | 68.0a | 0.332 | 1.410 (0.704–2.826) | 0.147 | 1.690 (0.832–3.435) | |
| CC + TC vs. TT | 0.961 | 1.013 (0.612–1.674) | 0.501 | 1.192 (0.715–1.985) | ||||
| CC vs. TC + TT | 0.224 | 1.501 (0.780–2.888) | 0.152 | 1.628 (0.836–3.170) | ||||
| H. pylori infection | n = 287 | n = 120 | ||||||
| Positive | TT | 76 | 29 | 56.7b | ||||
| TC | 56 | 23 | 79.0a | 0.660 | 1.131 (0.654–1.956) | 0.108 | 1.583 (0.904–2.772) | |
| CC | 20 | 6 | 63.1b | 0.437 | 0.705 (0.292–1.700) | 0.549 | 0.760 (0.309–1.865) | |
| CC + TC vs. TT | 0.999 | 1.000 (0.597–1.673) | 0.294 | 1.329 (0.781–2.261) | ||||
| CC vs. TC + TT | 0.338 | 0.661 (0.284–1.542) | 0.345 | 0.662 (0.282–1.557) | ||||
| Negative | TT | 61 | 29 | 58.0a | ||||
| TC | 53 | 21 | 54.1b | 0.427 | 0.796 (0.454–1.397) | 0.488 | 0.816 (0.460–1.450) | |
| CC | 21 | 12 | 29.0a | 0.361 | 1.369 (0.698–2.686) | 0.101 | 1.792 (0.893–3.595) | |
| CC + TC vs. TT | 0.779 | 0.931 (0.565–1.534) | 0.902 | 0.969 (0.586–1.604) | ||||
| CC vs. TC + TT | 0.196 | 1.516 (0.807–2.850) | 0.080 | 1.794 (0.932–3.454) | ||||
Borrmann classification, TNM staging, lymph node metastasis, and depth of invasion were taken as covariables.
Median survival time.
Mean survival time.